129 related articles for article (PubMed ID: 28601784)
1. Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base.
Miller BJ; Gao Y; Duchman KR
Cancer Epidemiol; 2017 Aug; 49():112-117. PubMed ID: 28601784
[TBL] [Abstract][Full Text] [Related]
2. Making a case for the socioeconomic determinacy of survival in osteosarcoma.
Nathan SS; Healey JH
Clin Orthop Relat Res; 2013 Mar; 471(3):784-91. PubMed ID: 22972655
[TBL] [Abstract][Full Text] [Related]
3. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.
Song K; Song J; Lin K; Chen F; Ma X; Jiang J; Li F
Int Orthop; 2019 Aug; 43(8):1983-1991. PubMed ID: 31127366
[TBL] [Abstract][Full Text] [Related]
5. Ninety Percent or Greater Tumor Necrosis Is Associated With Survival and Social Determinants of Health in Patients With Osteosarcoma in the National Cancer Database.
Richardson SM; Wurtz LD; Collier CD
Clin Orthop Relat Res; 2023 Mar; 481(3):512-522. PubMed ID: 36099400
[TBL] [Abstract][Full Text] [Related]
6. Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas.
Penumarthy NL; Goldsby RE; Shiboski SC; Wustrack R; Murphy P; Winestone LE
Cancer Med; 2020 Feb; 9(3):951-958. PubMed ID: 31838786
[TBL] [Abstract][Full Text] [Related]
7. Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
Restrepo DJ; Huayllani MT; Boczar D; Sisti A; Spaulding AC; Carter RE; Moran SL; Parker AS; Perdikis G; Forte AJ
Anticancer Res; 2019 Sep; 39(9):5027-5031. PubMed ID: 31519610
[TBL] [Abstract][Full Text] [Related]
8. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
[TBL] [Abstract][Full Text] [Related]
9. Adverse impact of regional lymph node involvement in osteosarcoma.
Thampi S; Matthay KK; Goldsby R; DuBois SG
Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database.
Duchman KR; Gao Y; Miller BJ
Cancer Epidemiol; 2015 Aug; 39(4):593-9. PubMed ID: 26002013
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
12. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
13. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
14. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
15. Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx.
Shin JY; Yoon JK; Shin AK; Blumenfeld P; Mai M; Diaz AZ
JAMA Otolaryngol Head Neck Surg; 2017 Sep; 143(9):899-907. PubMed ID: 28662244
[TBL] [Abstract][Full Text] [Related]
16. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
17. Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database.
Malik AT; Baek J; Alexander JH; Voskuil RT; Khan SN; Scharschmidt TJ
J Surg Oncol; 2020 Jun; 121(7):1097-1103. PubMed ID: 32133661
[TBL] [Abstract][Full Text] [Related]
18. Characterization of localized osteosarcoma of the extremity in children, adolescents, and young adults from a single institution in South Texas.
Sugalski AJ; Jiwani A; Ketchum NS; Cornell J; Williams R; Heim-Hall J; Hung JY; Langevin AM
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e353-8. PubMed ID: 24487915
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract][Full Text] [Related]
20. Demographic determinants of survival in osteosarcoma.
Nathan SS; Healey JH
Ann Acad Med Singap; 2012 Sep; 41(9):390-9. PubMed ID: 23052433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
